J Cardiovasc Nurs. 2003 Jan-Mar;18(1):11-6.

Drug-eluting stents to prevent reblockage of coronary arteries.

Source

Department of Medical Surgical Nursing, University of Illinois, Chicago, Illinois, USA.

Abstract

Restenosis limits the success of percutaneous transluminal coronary interventions. Coronary artery stenting decreases restenosis, improves outcomes, and is currently the most commonly used percutaneous coronary intervention in the United States. However, in-stent restenosis continues to occur at an unacceptable rate. In-stent restenosis is a neointimal hyperplastic response resulting primarily from vascular smooth muscle cell proliferation. Treatment with anti-proliferative agents presents a logical approach to eradicating restenosis, however, these drugs are highly toxic. Coating stents with anti-proliferative agents allows local delivery of high doses and avoids systemic side effects. In 2001, the results of two clinical trials, RAVEL and ELUTES, using sirolimus- and paclitaxil-coated stents demonstrated nearly complete elimination of in-stent restenosis. These dramatic results represent a tremendous advance in the treatment of coronary heart disease.

PMID:: 12537084; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Angioplasty - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Related citations

Review Perspectives of drug-eluting stents: the next revolution. [Am J Cardiovasc Drugs. 2002]
Review Perspectives of drug-eluting stents: the next revolution.
Moses JW, Kipshidze N, Leon MB. Am J Cardiovasc Drugs. 2002; 2(3):163-72.
Review Drug-eluting stent: the emerging technique for the prevention of restenosis. [Minerva Cardioangiol. 2002]
Review Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I, Carrieri L, Catuzzo B, Destefanis P, Oliaro E, Moretti C, Trevi GP. Minerva Cardioangiol. 2002 Oct; 50(5):443-53.
Review Drug-eluting stents. [Arch Cardiol Mex. 2006]
Review Drug-eluting stents.
García-García HM, Vaina S, Tsuchida K, Serruys PW. Arch Cardiol Mex. 2006 Jul-Sep; 76(3):297-319.
Review Paclitaxel-eluting stents in coronary artery disease. [Am J Health Syst Pharm. 2005]
Review Paclitaxel-eluting stents in coronary artery disease.
Nawarskas JJ, Osborn LA. Am J Health Syst Pharm. 2005 Nov 1; 62(21):2241-51.
Review Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer? [Singapore Med J. 2003]
Review Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
Lim VY, Lim YL. Singapore Med J. 2003 Sep; 44(9):482-7.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Drug-eluting stents to prevent reblockage of coronary arteries.
Drug-eluting stents to prevent reblockage of coronary arteries.
J Cardiovasc Nurs. 2003 Jan-Mar ;18(1):11-6.

PubMed
Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in a...
Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.
Indian J Ophthalmol. 2007 Jan-Feb ;55(1):75-6.

PubMed
Risk factors for major bleeding in patients with heparin-induced thrombocytopeni...
Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
J Cardiovasc Pharmacol. 2008 Dec ;52(6):561-6.

PubMed
A randomized trial of a single dose of oral dexamethasone for mild croup.
A randomized trial of a single dose of oral dexamethasone for mild croup.
J Pediatr. 2005 Mar ;146(3):434-5.

PubMed
Crystal structure of human mitochondrial acyl-CoA thioesterase (ACOT2).
Crystal structure of human mitochondrial acyl-CoA thioesterase (ACOT2).
Biochem Biophys Res Commun. 2009 Aug 7 ;385(4):630-3. Epub 2009 Jun 2 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: